Prior curative-intent treatment strategy affects progression outcomes of first-line immunotherapy in metastatic non-small cell lung cancer: A retrospective cohort study.

Exp Ther Med · 2026 · PMC13040668 · PMID 41929530

Europe PMC DOI

hedged sentences

0.0550

closest p · 1.1× alpha

0.0550

boldest claim

The sentences

did not reach statistical significanceP=0.055so close (0.05 < p ≤ 0.1)

This difference did not reach statistical significance using the χ2 test, yielding a borderline result (P=0.055).

also in 75,281 other papers

a possible trendno p-value reported

The present study indicated a possible trend for a lower risk of disease progression in patients previously treated with definitive chemoradiotherapy compared with those who received adjuvant chemotherapy; however, this was not statistically significant.

also in 939 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.